In response to the Epstein Files Transparency Act, the Justice Department released what Deputy Attorney General Todd Blanche called “several hundred thousand” Epstein documents on Friday, December 19.
Disclaimer: Trastuzumab deruxtecan has not been approved by the FDA for the neoadjuvant or adjuvant setting for early-stage, ...
Introduction Sleep problems are an escalating global health concern, with prevalence estimates ranging from 8.3% to 45%. Physicians are disproportionately affected, with rates around 44% compared with ...